These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 37647412)

  • 1. Structures of wild-type and selected CMT1X mutant connexin 32 gap junction channels and hemichannels.
    Qi C; Lavriha P; Bayraktar E; Vaithia A; Schuster D; Pannella M; Sala V; Picotti P; Bortolozzi M; Korkhov VM
    Sci Adv; 2023 Sep; 9(35):eadh4890. PubMed ID: 37647412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal gene therapy in mouse models expressing CMT1X mutations.
    Kagiava A; Karaiskos C; Richter J; Tryfonos C; Lapathitis G; Sargiannidou I; Christodoulou C; Kleopa KA
    Hum Mol Genet; 2018 Apr; 27(8):1460-1473. PubMed ID: 29462293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease.
    Abrams CK; Bennett MV; Verselis VK; Bargiello TA
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3980-4. PubMed ID: 11891346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cx32 hemichannel opening by cytosolic Ca2+ is inhibited by the R220X mutation that causes Charcot-Marie-Tooth disease.
    Carrer A; Leparulo A; Crispino G; Ciubotaru CD; Marin O; Zonta F; Bortolozzi M
    Hum Mol Genet; 2018 Jan; 27(1):80-94. PubMed ID: 29077882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Golgi-retained Cx32 mutants interfere with gene addition therapy for CMT1X.
    Kyriakoudi S; Sargiannidou I; Kagiava A; Olympiou M; Kleopa KA
    Hum Mol Genet; 2017 May; 26(9):1622-1633. PubMed ID: 28334782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of connexin-32 mutants associated with X-linked dominant Charcot-Marie-Tooth disease.
    Wang HL; Chang WT; Yeh TH; Wu T; Chen MS; Wu CY
    Neurobiol Dis; 2004 Mar; 15(2):361-70. PubMed ID: 15006706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease.
    Olympiou M; Sargiannidou I; Markoullis K; Karaiskos C; Kagiava A; Kyriakoudi S; Abrams CK; Kleopa KA
    Acta Neuropathol Commun; 2016 Sep; 4(1):95. PubMed ID: 27585976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connexins, gap junctions and peripheral neuropathy.
    Kleopa KA; Sargiannidou I
    Neurosci Lett; 2015 Jun; 596():27-32. PubMed ID: 25449862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations.
    Castro C; Gómez-Hernandez JM; Silander K; Barrio LC
    J Neurosci; 1999 May; 19(10):3752-60. PubMed ID: 10234007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease.
    Abrams CK; Oh S; Ri Y; Bargiello TA
    Brain Res Brain Res Rev; 2000 Apr; 32(1):203-14. PubMed ID: 10751671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gap junction disorders of myelinating cells.
    Kleopa KA; Orthmann-Murphy J; Sargiannidou I
    Rev Neurosci; 2010; 21(5):397-419. PubMed ID: 21280457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease.
    Ressot C; Bruzzone R
    Brain Res Brain Res Rev; 2000 Apr; 32(1):192-202. PubMed ID: 10751670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of X-linked Charcot-Marie-Tooth disease.
    Kleopa KA; Scherer SS
    Neuromolecular Med; 2006; 8(1-2):107-22. PubMed ID: 16775370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice.
    Scherer SS; Xu YT; Messing A; Willecke K; Fischbeck KH; Jeng LJ
    J Neurosci; 2005 Feb; 25(6):1550-9. PubMed ID: 15703409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32.
    Abrams CK; Freidin M; Bukauskas F; Dobrenis K; Bargiello TA; Verselis VK; Bennett MV; Chen L; Sahenk Z
    J Neurosci; 2003 Nov; 23(33):10548-58. PubMed ID: 14627639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease.
    Sargiannidou I; Kagiava A; Bashiardes S; Richter J; Christodoulou C; Scherer SS; Kleopa KA
    Ann Neurol; 2015 Aug; 78(2):303-16. PubMed ID: 26010264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot-Marie-Tooth disease.
    Abrams CK; Freidin MM; Verselis VK; Bennett MV; Bargiello TA
    Brain Res; 2001 May; 900(1):9-25. PubMed ID: 11325342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's the Function of Connexin 32 in the Peripheral Nervous System?
    Bortolozzi M
    Front Mol Neurosci; 2018; 11():227. PubMed ID: 30042657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked Charcot-Marie-Tooth disease.
    Scherer SS; Kleopa KA
    J Peripher Nerv Syst; 2012 Dec; 17 Suppl 3(0 3):9-13. PubMed ID: 23279425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease?
    Kleopa KA; Abrams CK; Scherer SS
    Brain Res; 2012 Dec; 1487():198-205. PubMed ID: 22771394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.